Cargando…
First-in-Humans Study of (68)Ga-DOTA-Siglec-9, a PET Ligand Targeting Vascular Adhesion Protein 1
Sialic acid–binding immunoglubulinlike lectin 9 (Siglec-9) is a ligand of vascular adhesion protein 1. A (68)Ga-labeled peptide of Siglec-9, (68)Ga-DOTA-Siglec-9, holds promise as a novel PET tracer for imaging of inflammation. This first-in-humans study investigated the safety, tolerability, biodis...
Autores principales: | Viitanen, Riikka, Moisio, Olli, Lankinen, Petteri, Li, Xiang-Guo, Koivumäki, Mikko, Suilamo, Sami, Tolvanen, Tuula, Taimen, Kirsi, Mali, Markku, Kohonen, Ia, Koskivirta, Ilpo, Oikonen, Vesa, Virtanen, Helena, Santalahti, Kristiina, Autio, Anu, Saraste, Antti, Pirilä, Laura, Nuutila, Pirjo, Knuuti, Juhani, Jalkanen, Sirpa, Roivainen, Anne |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Society of Nuclear Medicine
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8049366/ https://www.ncbi.nlm.nih.gov/pubmed/32817143 http://dx.doi.org/10.2967/jnumed.120.250696 |
Ejemplares similares
-
Comparison of (68)Ga-DOTA-Siglec-9 and (18)F-Fluorodeoxyribose-Siglec-9: Inflammation Imaging and Radiation Dosimetry
por: Virtanen, Helena, et al.
Publicado: (2017) -
(68)Ga-DOTA-Siglec-9 – a new imaging tool to detect synovitis
por: Virtanen, Helena, et al.
Publicado: (2015) -
Adventures in radiosynthesis of clinical grade [(68)Ga]Ga-DOTA-Siglec-9
por: Käkelä, Meeri, et al.
Publicado: (2018) -
[(68)Ga]Ga-DOTA-Siglec-9 Detects Pharmacodynamic Changes of FAP-Targeted IL2 Variant Immunotherapy in B16-FAP Melanoma Mice
por: Viitanen, Riikka, et al.
Publicado: (2022) -
Safety Study of Single-Dose Intravenously Administered DOTA-Siglec-9 Peptide in Sprague Dawley Rats
por: Chrusciel, Paulina, et al.
Publicado: (2019)